SynthesisJournal of neuro-oncology2016

Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.

Sang Hyun Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.